Latest Overdiagnosis Stories
WASHINGTON, May 29 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) said that the American Cancer Society's claim of "progress in cancer fight" earlier this week was based on "selective culling of statistics and ignores the dismal truth that we have made very little progress on the most lethal cancers, including lung cancer, which causes one in every two cancer deaths, or in metastatic cancer of any kind." (Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO) LCA President &...
The debate continues as an influential group of doctors relax the call for annual prostate cancer screening for men over the age of 50.
ARNHEM, The Netherlands, April 16 /PRNewswire/ -- The European Association of Urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on prostate cancer (SchrÃƒÂ¶der et al, NEJM 2009).
The results of two large, long-awaited studies show that prostate cancer screening does not necessarily save lives, and in some cases may lead to unneeded treatments with serious side effects.
Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online 1700 hours CET, today 18 March (NEJM, Online First*)
STOCKHOLM, Sweden, March 18 /PRNewswire/ -- - Attn: Healthcare Editors Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online 1700 hours CET 18 March (NEJM, Online First*).
Despite efforts to promote early screening, low-income men may be waiting too long for prostate cancer screening.
By H. Gilbert Welch, M.D. In a U.S. presidential campaign that promises straight talk and no gimmicks, why do both candidates champion one of medical care's most pervasive myths? The myth is that like magic, preventive medicine will simultaneously reduce costs and improve health.
REHOVOT, Israel, September 24 /PRNewswire-FirstCall/ -- BioView Ltd, from Rehovot, Israel, reported today results of its internal clinical trial of the non-invasive diagnostic test under development for early detection of lung cancer.
By WILLIAM J CATALONA Many media reports followed a federal task force's announcement this month that there is insufficient medical evidence to assess the risks and benefits of prostate cancer screening in men younger than 75 and that doctors should stop testing men over age 75.
- A hairdresser.